Newsfeeds Archive - Spark Newswire

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

May 22, 12:31 PM

Gainers IGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday’s regular session. The market value of…

AHG

1 minute read

Eagle Pharmaceuticals Announces A Trial In Progress Presentation Of Phase 2/3 Study Of Intravenous Amisulpride As Prevention Of Postoperative Nausea And Vomiting In Pediatric Patients At The Upcoming Society For Ambulatory Anesthesia 2024 Annual Meetin…

By Benzinga Newsdesk

April 30, 8:06 AM

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today announced that it will deliver a Trial in Progress presentation discussing the ongoing Phase 2/3 study of intravenous amisulpride as a

EGRX

2 minute read

Eagle Pharmaceuticals To Present Abstract On Post-Hoc Analysis Of Amisulpride At The 77th PGA In New York City

By Benzinga Newsdesk

December 6, 5:29 PM

-- BARHEMSYS® (amisulpride) Injection is the first and only antiemetic approved by the U.S. Food and Drug Administration ("FDA") for rescue treatment of postoperative nausea and vomiting ("PONV") despite

EGRX

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

November 30, 5:31 PM

Gainers Altimmune (NASDAQ:ALT) shares increased by 45.2% to $4.59 during Thursday’s after-market session. The company’s market cap stands…

AKAN

4 minute read

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

November 29, 3:02 PM

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

ATXI